{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T20:58:03Z","timestamp":1790888283509,"version":"4.1.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"vor","delay-in-days":54,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-49030-z","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T22:05:39Z","timestamp":1776377139000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The relationship between abdominal obesity indices and the risk of metabolic dysfunction-associated fatty liver disease: a prospective cohort study"],"prefix":"10.1038","volume":"16","author":[{"given":"Shi-Long","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Xia","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Han","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Hao","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-Jie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Yu","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,16]]},"reference":[{"issue":"21","key":"49030_CR1","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1056\/NEJMra1503519","volume":"377","author":"AM Diehl","year":"2017","unstructured":"Diehl, A. M. & Day, C. Cause, pathogenesis, and treatment of nonalcoholic steatohepatitis. N. Engl. J. Med. 377(21), 2063\u20132072 (2017).","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"49030_CR2","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.jhep.2023.04.036","volume":"79","author":"VW-S Wong","year":"2023","unstructured":"Wong, V.W.-S. et al. Changing epidemiology, global trends and implications for outcomes of NAFLD. J. Hepatol. 79(3), 842\u2013852 (2023).","journal-title":"J. Hepatol."},{"issue":"4","key":"49030_CR3","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","volume":"77","author":"ZM Younossi","year":"2023","unstructured":"Younossi, Z. M. et al. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): A systematic review. Hepatology 77(4), 1335\u20131347 (2023).","journal-title":"Hepatology"},{"issue":"2","key":"49030_CR4","doi-asserted-by":"publisher","first-page":"e76","DOI":"10.1016\/j.jhep.2023.08.026","volume":"80","author":"H Hagstr\u00f6m","year":"2024","unstructured":"Hagstr\u00f6m, H. et al. 99% of patients with NAFLD meet MASLD criteria and natural history is therefore identical. J. Hepatol. 80(2), e76\u2013e77 (2024).","journal-title":"J. Hepatol."},{"issue":"9","key":"49030_CR5","doi-asserted-by":"publisher","first-page":"2691","DOI":"10.1210\/clinem\/dgac321","volume":"107","author":"KE Chan","year":"2022","unstructured":"Chan, K. E. et al. Global prevalence and clinical characteristics of metabolic-associated fatty liver disease: A Meta-analysis and systematic review of 10 739 607 individuals. J. Clin. Endocrinol. Metab. 107(9), 2691\u20132700 (2022).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"10319","key":"49030_CR6","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S0140-6736(21)01701-3","volume":"399","author":"TH Karlsen","year":"2022","unstructured":"Karlsen, T. H. et al. The EASL-Lancet liver commission: Protecting the next generation of Europeans against liver disease complications and premature mortality. Lancet 399(10319), 61\u2013116 (2022).","journal-title":"Lancet"},{"issue":"4","key":"49030_CR7","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.jhep.2018.05.036","volume":"69","author":"C Estes","year":"2018","unstructured":"Estes, C. et al. Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016\u20132030. J. Hepatol. 69(4), 896\u2013904 (2018).","journal-title":"J. Hepatol."},{"key":"49030_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/nu14122361","author":"Y Guo","year":"2022","unstructured":"Guo, Y. et al. Metabolic dysfunction-associated fatty liver disease is associated with the risk of incident cardiovascular disease: A prospective cohort study in Xinjiang. Nutrients https:\/\/doi.org\/10.3390\/nu14122361 (2022).","journal-title":"Nutrients"},{"issue":"3","key":"49030_CR9","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.ecl.2023.01.005","volume":"52","author":"P Vidal-Cevallos","year":"2023","unstructured":"Vidal-Cevallos, P. et al. The interlink between metabolic-associated fatty liver disease and polycystic ovary syndrome. Endocrinol. Metab. Clin. North Am. 52(3), 533\u2013545 (2023).","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"49030_CR10","doi-asserted-by":"publisher","first-page":"154955","DOI":"10.1016\/j.metabol.2021.154955","volume":"127","author":"Z Liu","year":"2022","unstructured":"Liu, Z. et al. Metabolic dysfunction-associated fatty liver disease and the risk of 24 specific cancers. Metab. clin. Exp. 127, 154955 (2022).","journal-title":"Metab. clin. Exp."},{"key":"49030_CR11","doi-asserted-by":"publisher","first-page":"154433","DOI":"10.1016\/j.metabol.2020.154433","volume":"115","author":"D-Q Sun","year":"2021","unstructured":"Sun, D.-Q. et al. MAFLD and risk of CKD. Metab. Clin. Exp. 115, 154433 (2021).","journal-title":"Metab. Clin. Exp."},{"issue":"1","key":"49030_CR12","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.cgh.2015.07.024","volume":"14","author":"D Kim","year":"2016","unstructured":"Kim, D. et al. Body Fat Distribution and Risk of Incident and Regressed Nonalcoholic Fatty Liver Disease. Clinical gastroenterology and hepatology\u202f: The official clinical practice journal of the American Gastroenterological Association 14(1), 132\u20138.e4 (2016).","journal-title":"Clinical gastroenterology and hepatology : The official clinical practice journal of the American Gastroenterological Association"},{"issue":"10","key":"49030_CR13","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/s41574-024-01012-9","volume":"20","author":"E B\u00f6rgeson","year":"2024","unstructured":"B\u00f6rgeson, E. et al. The challenges of assessing adiposity in a clinical setting. Nat. Rev. Endocrinol. 20(10), 615\u2013626 (2024).","journal-title":"Nat. Rev. Endocrinol."},{"issue":"6","key":"49030_CR14","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.15051","volume":"7","author":"X Zhang","year":"2024","unstructured":"Zhang, X. et al. Body roundness index and all-cause mortality among US adults. JAMA Netw Open. 7(6), e2415051 (2024).","journal-title":"JAMA Netw Open."},{"issue":"1","key":"49030_CR15","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s12933-020-01095-4","volume":"19","author":"H Wan","year":"2020","unstructured":"Wan, H. et al. Associations between abdominal obesity indices and diabetic complications: Chinese visceral adiposity index and neck circumference. Cardiovasc. Diabetol. 19(1), 118 (2020).","journal-title":"Cardiovasc. Diabetol."},{"issue":"1","key":"49030_CR16","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/s12933-025-02761-1","volume":"24","author":"L Zhou","year":"2025","unstructured":"Zhou, L. et al. Long-term dual-trajectories of TyG and LAP and their association with cardiometabolic multimorbidity in midlife: The CARDIA study. Cardiovasc. Diabetol. 24(1), 198 (2025).","journal-title":"Cardiovasc. Diabetol."},{"issue":"9","key":"49030_CR17","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1002\/ejhf.1244","volume":"20","author":"KW Streng","year":"2018","unstructured":"Streng, K. W. et al. Waist-to-hip ratio and mortality in heart failure. Eur. J. Heart Fail. 20(9), 1269\u20131277 (2018).","journal-title":"Eur. J. Heart Fail."},{"key":"49030_CR18","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1471-230X-6-33","volume":"6","author":"G Bedogni","year":"2006","unstructured":"Bedogni, G. et al. The Fatty Liver Index: A simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 6, 33 (2006).","journal-title":"BMC Gastroenterol."},{"issue":"7","key":"49030_CR19","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.dld.2009.08.002","volume":"42","author":"J-H Lee","year":"2010","unstructured":"Lee, J.-H. et al. Hepatic steatosis index: A simple screening tool reflecting nonalcoholic fatty liver disease. Dig. Liver Dis. 42(7), 503\u2013508 (2010).","journal-title":"Dig. Liver Dis."},{"issue":"9","key":"49030_CR20","doi-asserted-by":"publisher","DOI":"10.5812\/hepatmon.39575","volume":"16","author":"N Motamed","year":"2016","unstructured":"Motamed, N. et al. Body roundness index and waist-to-height ratio are strongly associated with non-alcoholic fatty liver disease: A population-based study. Hepat. Mon. 16(9), e39575 (2016).","journal-title":"Hepat. Mon."},{"issue":"1","key":"49030_CR21","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s12944-025-02544-3","volume":"24","author":"S Khanmohammadi","year":"2025","unstructured":"Khanmohammadi, S. et al. Effectiveness of body roundness index for the prediction of nonalcoholic fatty liver disease: A systematic review and meta-analysis. Lipids Health Dis. 24(1), 117 (2025).","journal-title":"Lipids Health Dis."},{"issue":"1","key":"49030_CR22","doi-asserted-by":"publisher","first-page":"21189","DOI":"10.1038\/s41598-024-72482-0","volume":"14","author":"Y-J Lee","year":"2024","unstructured":"Lee, Y.-J. et al. Effects of MAFLD defined by Fatty Liver Index or ultrasonography on kidney function decline in the general population. Sci. Rep. 14(1), 21189 (2024).","journal-title":"Sci. Rep."},{"issue":"1 Suppl 1","key":"49030_CR23","first-page":"S27","volume":"48","author":"ADAPP Committee","year":"2025","unstructured":"Committee, A. D. A. P. P. 2. Diagnosis and classification of diabetes: Standards of care in diabetes-2025. Diabetes Care 48(1 Suppl 1), S27\u2013S49 (2025).","journal-title":"Diabetes Care"},{"issue":"11","key":"49030_CR24","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1002\/oby.20408","volume":"21","author":"DM Thomas","year":"2013","unstructured":"Thomas, D. M. et al. Relationships between body roundness with body fat and visceral adipose tissue emerging from a new geometrical model. Obesity 21(11), 2264\u20132271 (2013).","journal-title":"Obesity"},{"key":"49030_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/srep38214","volume":"6","author":"M-F Xia","year":"2016","unstructured":"Xia, M.-F. et al. A indicator of visceral adipose dysfunction to evaluate metabolic health in adult Chinese. Sci. Rep. 6, 38214 (2016).","journal-title":"Sci. Rep."},{"issue":"1","key":"49030_CR26","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","volume":"73","author":"M Eslam","year":"2020","unstructured":"Eslam, M. et al. A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement. J. Hepatol. 73(1), 202\u2013209 (2020).","journal-title":"J. Hepatol."},{"issue":"1","key":"49030_CR27","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s12944-021-01568-9","volume":"20","author":"J Cai","year":"2021","unstructured":"Cai, J. et al. Waist-to-height ratio, an optimal anthropometric indicator for metabolic dysfunction associated fatty liver disease in the Western Chinese male population. Lipids Health Dis. 20(1), 145 (2021).","journal-title":"Lipids Health Dis."},{"key":"49030_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.935980","volume":"13","author":"M Tang","year":"2022","unstructured":"Tang, M. et al. Association between Chinese visceral adiposity index and metabolic-associated fatty liver disease in Chinese adults with type 2 diabetes mellitus. Front. Endocrinol. 13, 935980 (2022).","journal-title":"Front. Endocrinol."},{"key":"49030_CR29","doi-asserted-by":"crossref","unstructured":"Peng, H., et al. Prediction of MAFLD and NAFLD using different screening indexes: A cross-sectional study in U.S. adults.  Front. Endocrinol. 14 1083032 (2023).","DOI":"10.3389\/fendo.2023.1083032"},{"key":"49030_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.831960","volume":"13","author":"X Chen","year":"2022","unstructured":"Chen, X. et al. Associations between abdominal obesity indices and nonalcoholic fatty liver disease: Chinese visceral adiposity index. Front. Endocrinol. 13, 831960 (2022).","journal-title":"Front. Endocrinol."},{"issue":"1","key":"49030_CR31","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s12933-023-01926-0","volume":"22","author":"J Bai","year":"2023","unstructured":"Bai, J. et al. Correlation analysis of the abdominal visceral fat area with the structure and function of the heart and liver in obesity: A prospective magnetic resonance imaging study. Cardiovasc. Diabetol. 22(1), 206 (2023).","journal-title":"Cardiovasc. Diabetol."},{"key":"49030_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-024-01103-8","author":"H Tilg","year":"2024","unstructured":"Tilg, H. et al. Adipokines: Masterminds of metabolic inflammation. Nat. Rev. Immunol. https:\/\/doi.org\/10.1038\/s41577-024-01103-8 (2024).","journal-title":"Nat. Rev. Immunol."},{"issue":"5","key":"49030_CR33","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1007\/s00125-019-4820-6","volume":"62","author":"O Bello","year":"2019","unstructured":"Bello, O. et al. Black African men with early type 2 diabetes have similar muscle, liver and adipose tissue insulin sensitivity to White European men despite lower visceral fat. Diabetologia 62(5), 835\u2013844 (2019).","journal-title":"Diabetologia"},{"issue":"1","key":"49030_CR34","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12944-022-01763-2","volume":"21","author":"P Yu","year":"2022","unstructured":"Yu, P. et al. Gender differences in the ideal cutoffs of visceral fat area for predicting MAFLD in China. Lipids Health Dis. 21(1), 148 (2022).","journal-title":"Lipids Health Dis."},{"key":"49030_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2261-5-26","volume":"5","author":"HS Kahn","year":"2005","unstructured":"Kahn, H. S. The \u201clipid accumulation product\u201d performs better than the body mass index for recognizing cardiovascular risk: A population-based comparison. BMC Cardiovasc. Dis. 5, 26 (2005).","journal-title":"BMC Cardiovasc. Dis."},{"issue":"1","key":"49030_CR36","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1038\/s41467-023-36775-8","volume":"14","author":"J Wu","year":"2023","unstructured":"Wu, J. et al. The rhythmic coupling of Egr-1 and Cidea regulates age-related metabolic dysfunction in the liver of male mice. Nat. Commun. 14(1), 1634 (2023).","journal-title":"Nat. Commun."},{"key":"49030_CR37","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.arr.2016.09.008","volume":"35","author":"A Kalinkovich","year":"2017","unstructured":"Kalinkovich, A. & Livshits, G. Sarcopenic obesity or obese sarcopenia: A cross talk between age-associated adipose tissue and skeletal muscle inflammation as a main mechanism of the pathogenesis. Ageing Res. Rev. 35, 200\u2013221 (2017).","journal-title":"Ageing Res. Rev."},{"issue":"7","key":"49030_CR38","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1056\/NEJMra2412865","volume":"393","author":"G Targher","year":"2025","unstructured":"Targher, G., Valenti, L. & Byrne, C. D. Metabolic dysfunction-associated steatotic liver disease. N. Engl. J. Med. 393(7), 683\u2013698 (2025).","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"49030_CR39","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.jhep.2009.09.001","volume":"51","author":"S Dasarathy","year":"2009","unstructured":"Dasarathy, S. et al. Validity of real time ultrasound in the diagnosis of hepatic steatosis: A prospective study. J. Hepatol. 51(6), 1061\u20131067 (2009).","journal-title":"J. Hepatol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-49030-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-49030-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-49030-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T23:31:28Z","timestamp":1780961488000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-49030-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,16]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["49030"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-49030-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,16]]},"assertion":[{"value":"10 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Institutional Ethics Review Board (IERB) of the First Affiliated Hospital of Shihezi University School of Medicine (IERB no.: 2016\u2013121\u201301).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all subjects involved in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"17777"}}